755. Vaccine-Preventable Disease and the Underutilization of Immunizations in Complex Humanitarian Emergencies
Session: Poster Abstract Session: Vaccines: Pediatric
Thursday, October 27, 2016
Room: Poster Hall
Posters
  • CHE.Close.Pearson.Cohn.pdf (359.8 kB)
  • Background: Complex humanitarian emergencies (CHE) affect 40 to 60 million people annually. Despite efforts to provide medical and public health services to those affected by CHE, significant morbidity and mortality persist. We argue that vaccination is an essential tool for preventing mortality in CHE that is currently underutilized and poorly standardized. Only measles vaccine is distributed universally in humanitarian crises. All others are considered for use via a decision-making tool created by the Strategic Advisory Group of Experts on Immunization at the WHO, which uses geographic factors, disaster types, and host factors to select appropriate vaccines in emergencies. We hypothesize that the current tool incorrectly assumes variability in vaccine-preventable disease (VPD) across environments experiencing crises. We review the available literature on disease epidemiology in CHE across the globe and discuss implications for vaccine choice and distribution.

    Methods: We undertook a review of original research and reviews, using MEDLINE, PubMed, SCOPUS, and the databases of the WHO, CDC, UNHCR, UNICEF, and SPHERE. Keywords and focused MeSH terms included: refugee, displaced person, population displacement, disaster, disaster planning, relief work, communicable disease, vaccination and specific diseases and vaccines. All abstracts were assessed for relevance; those deemed topical were reviewed in more detail.

    Results: Over 200 papers were reviewed and 97 included in the final analysis. Throughout the literature, independent of geography, time, and crisis-type, the two most common causes of death in humanitarian emergencies are acute respiratory illness and diarrheal disease. Within these, the majority of disease is cause by three pathogens: Streptococcus pneumoniae, Rotavirus, and Haemophilus influenzae type-b.

    Conclusion: A limited number of VPD contribute disproportionately to morbidity and mortality in CHE. The literature suggests that Streptococcus pneumoniae, Rotavirus, and Haemophilus influenzae type-b are essential targets for vaccination programs in emergencies. These three vaccines should be considered for universal use in CHE. Strategies such as reduced dosing schedules and expanded age range of vaccine administration should be investigated to overcome the barriers to distribution.

    Catherine Pearson, MD, Internal Medicine, University of Pennsylvania, Philadelphia, PA, Ryan Close, MD MPH, Internal Medicine, Pediatrics, University of Pennsylvania, Philadelphia, PA and Jennifer Cohn, MD MPH, Infectious Diseases, Hospital of the University of Pennsylvania, Geneva, Switzerland

    Disclosures:

    C. Pearson, None

    R. Close, None

    J. Cohn, None

    See more of: Vaccines: Pediatric
    See more of: Poster Abstract Session
    Previous Abstract | Next Abstract >>

    Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.